← All trials
NCT06337474
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 30, 2024
- Primary completion
- Mar 30, 2025
- Completion date
- Mar 30, 2026
- First posted
- Mar 29, 2024
- Last posted
- Jul 22, 2024
- Enrollment
- 9
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Changzhou No.2 People's HospitalLead sponsor
- Changzhou No.2 People's HospitalSponsor investigator
- Rui Therapeutics Co., LtdCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.